3-Azabicyclo[4.1.0]heptan-1-ol hydrochloride

Catalog No. :
ACXVPL754
CAS No. :
1394042-85-3
Molecular Formula :
C6H12ClNO
Molecular Weight :
149.62

IUPAC Name:3-azabicyclo[4.1.0]heptan-1-ol hydrochloride

3-Azabicyclo[4.1.0]heptan-1-ol hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$322.00Login to see priceInquiryInquiry
250mg95%$548.00Login to see priceInquiryInquiry
500mg95%$966.00Login to see priceInquiryInquiry
1g95%$1770.00Login to see priceInquiryInquiry
5g95%$7018.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Azabicyclo[4.1.0]heptan-1-ol hydrochloride
IUPAC Name3-azabicyclo[4.1.0]heptan-1-ol hydrochloride
MDL No.MFCD22378740
Molecular FormulaC6H12ClNO
Molecular Weight149.62
SMILESOC12CNCCC1C2.[H]Cl
InChI KeyRPSQCPWZNRRTFQ-UHFFFAOYSA-N
SynonymEN300-110131 | 3-azabicyclo[4.1.0]heptan-1-olhydrochloride | SCHEMBL20531943 | 1394042-85-3 | 3-Azabicyclo[4.1.0]heptan-1-ol HCl | MFCD22378740 | PS-17963 | SB74970 | SY141171 | D96795 | AKOS026741574 | rac-(1R,6R)-3-azabicyclo[4.1.0]heptan-1-ol hydrochlo
CAS No.1394042-85-3
PubChem CID71756408

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXVPL754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXVPL754 route product structure diagram
    ACXVPL7541394042-85-3
Inquiry

2. ACXVPL754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXVPL754 route product structure diagram
    ACXVPL7541394042-85-3
Inquiry

Comments (0)